Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Sumida, Takayuki, Mimori, Tsuneyo, Koike, Takao, Endo, Kazuhiro, Mashino, Naomi, Yamamoto, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://www.ncbi.nlm.nih.gov/pubmed/26054418
http://dx.doi.org/10.3109/14397595.2015.1060665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://www.ncbi.nlm.nih.gov/pubmed/26054418
http://dx.doi.org/10.3109/14397595.2015.1060665

Ejemplares similares